BioSpace News Archive

Nutriband Inc. announced that its Board of Directors has approved and declared a 7:6 forward split of its common stock that is expected to be effective at 12:01AM on August 15 and in effect at the opening of trading on Monday August 15, 2022.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced approval of its AcQMap High Resolution Imaging and Mapping System and the AcQMap 3D Imaging and Mapping Catheter in Japan.

Pfizer Inc. and BioNTech SE announced that the companies have initiated a randomized, active-controlled, observer-blind Phase 2 study to evaluate the safety, tolerability, and immune response of an enhanced COVID-19 mRNA-based vaccine candidate at a 30 µg dose level.

Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close.

Plandai Biotechnology, Inc. announces the termination of its non-binding letter of intent dated May 23, 2022, with Ms. Jessie Chiang, license holder of the worldwide rights, exclusive of Taiwan, of the Puriblood Leukocyte Reduction Blood Filtration System.

The global drug discovery services market is thriving on account of the rising impetus given to research and development across several industrial.

The Global bone growth stimulators market has been experiencing a positive transformation for the course of years.

Fact.MR - A Market Research And Competitive Intelligence Provider, the Americas hospital acquired infection testing market was valued at US$ 595 Million in 2020, and is expected to exhibit a CAGR of around 15% over the forecast period.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The catheters that are utilized to access the patient’s vascular system through veins are known as intravenous catheters.

Also known as genome editing with engineered nucleases, genome editing is a method of altering DNA within a cell in a safe manner.